In a significant advancement for Alzheimer’s disease diagnosis, the Food and Drug Administration (FDA) has cleared the first blood test for the disorder. Fujirebio Diagnostics’ Lumipulse test measures the ratio of two proteins in the blood that correlate with the presence or absence of Alzheimer’s. This less invasive option offers an alternative to previous screening methods like PET scans or spinal taps.
Read: There is now a blood test for early Alzheimer’s detection
In this week’s Tech Tuesday segment on Smile 90.4FM we discuss the groundbreaking new blood test for early Alzheimer’s detection.
Listen down below:
